Alopecia areata. Pathogenesis, diagnosis, and therapy

Area of Science:

• Dermatology
• Immunology
• Genetics

Background:

• Alopecia areata is a common non-scarring hair loss condition affecting all ages, often starting in childhood.
• Characterized by patchy scalp hair loss, it can progress to total scalp or body hair loss (alopecia totalis/universalis).
• Nail changes and associations with autoimmune diseases and specific human leukocyte antigen (HLA) class II alleles suggest an autoimmune basis.

Purpose of the Study:

• To review the clinical presentation, potential autoimmune etiology, and diagnostic methods for alopecia areata.
• To discuss current and potential therapeutic strategies for managing hair regrowth.
• To emphasize the need for individualized treatment approaches and ongoing patient management.

Main Methods:

• Clinical diagnosis is typical, though a biopsy can confirm the condition.
• Review of established and emerging treatments, including intralesional corticosteroids, topical anthralin, minoxidil, and sensitizers.
• Discussion of the challenges in developing a universal treatment algorithm due to patient variability.

Main Results:

• Alopecia areata involves T lymphocytes in its pathogenesis.
• Various treatments show efficacy, but patient response is inconsistent.
• Successful management relies on achieving cosmetic hair regrowth and implementing maintenance therapy.

Conclusions:

• Alopecia areata is a complex autoimmune condition requiring personalized treatment strategies.
• Effective management focuses on individual patient needs and achieving satisfactory hair regrowth.
• A strong patient-physician relationship is crucial for successful long-term outcomes and maintenance therapy.